Alternative system for detection and mapping of activation domains

BioTechniques

Volumn 22, Issue 5, 1997, Pages 948-951

  Ašković, Srdjan ^a   Baumann, Ray ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN DOMAIN; REPORTER GENE; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION;

FELIS CATUS; HUMAN HERPESVIRUS 4;

EID: 1842369701     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/97225rr02     Document Type: Article

References (14)

1. Adams, C. and J. Workman. 1995. Binding of disparate transcriptional activators to nucleosomal DNA is inherently cooperative. Mol. Cell. Biol. 15:1405-1421.
2. Baumann, R., E. Grogan, M. Ptashne and G. Miller. 1993. Changing Epstein-Barr viral ZEBRA protein into a more powerful activator enhances its capacity to disrupt latency. Proc. Natl. Acad. Sci. USA 90:4436-4440.
3. Baumann, R., G. Warren and S. Ašković. 1995. Restoration of the Epstein-Barr virus ZEBRA protein's capacity to disrupt latency by the addition of a heterologous activation region. Virology 211:64-72.
4. Carey, M., J. Kolman, D.A. Katz, L. Gradoville, L. Barberis and G. Miller. 1992. Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA. J. Virol. 66:4803-4813.
5. Davis, M.G. and E. Huang. 1988. Transfer and expression of plasmids containing human cytomegalovirus immediate-early gene 1 promoter enhancer sequences in eukaryotic and prokaryotic cells. Biotechnol. Appl. Biochem. 10:6-12.
6. Flemington, E.K., A.M. Borras, J.P. Lytle and S. Speck. 1992. Characterization of the Epstein-Barr virus BZLF1 protein transactivation domain. J. Virol. 66:922-929.
7. Gorman, C.M., L.F. Moffat and B.H. Howard. 1982. Recombinant genomes which express chloramphenicol acclyl-transferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
8. Jankelevich, S., J. Kolman, J. Bodnar and G. Miller. 1992. A nuclear matrix attachment region organizes the Epstein-Barr virus plasmid in Raji cells into a single DNA domain. EMBO J. 11:1165-1176.
9. Jones, D., L. Lee, J.-L. Liu, H.-J. Kung and J. Tillotson. 1992. Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc. Natl. Acad. Sci. USA 89:4042-4046.
10. Marshal, D. and C. Sample. 1995. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. J. Virol. 69:3624-3630.
11. Nielsen, D., T. Chang and D. Shapiro. 1989. A highly sensitive mixed-phase assay for chloramphenicol acetyltransferase activity in transfected cells. Anal. Biochem. 179:19-23.
12. Qian, Z., P. Brunovskis, F. Rancher III, L. Lee and H.-J. Kung. 1995. Transactivation activity of Meq, a Mareks disease herpesvirus bZIP protein persistently expressed in latently infected transformed T cells. J. Virol. 69:4037-4044.
13. Sadowski, I. and M. Ptashne. 1989. A vector for expressing GAL4 (1-147) fusions in mammalian cells. Nucleic Acids Res. 17:7539.
14. Seed, B. and J. Sheen. 1988. A simple phase-extraction assay for chloramphenicol acetyl-transferase activity. Gene 67:271-277.